These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 29642408)
21. A multicentre observational study on the epidemiology, risk factors, management and outcomes of mucormycosis in India. Patel A; Kaur H; Xess I; Michael JS; Savio J; Rudramurthy S; Singh R; Shastri P; Umabala P; Sardana R; Kindo A; Capoor MR; Mohan S; Muthu V; Agarwal R; Chakrabarti A Clin Microbiol Infect; 2020 Jul; 26(7):944.e9-944.e15. PubMed ID: 31811914 [TBL] [Abstract][Full Text] [Related]
22. Vacuum-Assisted Closure and Skin Grafting Combined with Amphotericin B for Successful Treatment of an Immunocompromised Patient with Cutaneous Mucormycosis Caused by Mucor irregularis: A Case Report and Literature Review. Tang X; Guo P; Wong H; Xie J; Han J; Xu Y; Zhou H Mycopathologia; 2021 Jun; 186(3):449-459. PubMed ID: 34131870 [TBL] [Abstract][Full Text] [Related]
23. Epidemiology and Diagnosis of Mucormycosis: An Update. Skiada A; Pavleas I; Drogari-Apiranthitou M J Fungi (Basel); 2020 Nov; 6(4):. PubMed ID: 33147877 [TBL] [Abstract][Full Text] [Related]
24. Microbiology Profile of COVID-19-Associated Rhino-Orbital Mucormycosis Pathogens in South India. Sheba E; Sharma S; Kumar Mishra D; Vivek Dave T; Ganguly Kapoor A; Joseph J Am J Trop Med Hyg; 2023 Feb; 108(2):377-383. PubMed ID: 36572009 [TBL] [Abstract][Full Text] [Related]
25. First report of rhino-orbital mucormycosis caused by Taghizadeh Armaki M; Jafarzadeh J; Mahdavi Omran S; Bayani M; Tavassoli A; Faeli L; Nosratabadi M; Yaalimadad S; Nikoueian B; Haghani I; Moazeni M; Shokohi T; Taghi Hedayati M; Abastabar M Curr Med Mycol; 2022 Jun; 8(2):49-54. PubMed ID: 36654791 [TBL] [Abstract][Full Text] [Related]
26. Rhino-orbito-cerebral mucormycosis caused by Rhizopus microsporus var. microsporus in a diabetic patient with COVID-19. Munhoz SD; Lellis RF; Reis APC; Del Negro GMB; Sousa MGT; Veasey JV An Bras Dermatol; 2022; 97(4):501-504. PubMed ID: 35691738 [TBL] [Abstract][Full Text] [Related]
27. [Cutaneous mucormycosis caused by Rhizopus microsporus]. Desoubeaux G; Leperlier M; Chaussade H; Schneider C; Roriz M; Houssin C; Rogez C; De Muret A; García-Hermoso D; Bailly É; Le Fourn É; Machet L; Chandenier J; Bernard L Ann Dermatol Venereol; 2014 Mar; 141(3):201-5. PubMed ID: 24635954 [TBL] [Abstract][Full Text] [Related]
28. Rise of mucormycosis during the COVID-19 pandemic and the challenges faced. Kottarathil M; Thayanidhi P; P S; Jyoti Kindo A Curr Med Mycol; 2023 Mar; 9(1):44-55. PubMed ID: 37867589 [TBL] [Abstract][Full Text] [Related]
29. Apophysomyces variabilis as an emerging pathogen in Mainland China. Li XY; Wang SJ; Huang GM; Zheng DY; Al-Odaini N; Pan KS; Zheng YQ; Cao CW Mycoses; 2023 Sep; 66(9):795-800. PubMed ID: 37226871 [TBL] [Abstract][Full Text] [Related]
31. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans. Liang KP; Tleyjeh IM; Wilson WR; Roberts GD; Temesgen Z J Clin Microbiol; 2006 Mar; 44(3):892-8. PubMed ID: 16517873 [TBL] [Abstract][Full Text] [Related]
32. [Pulmonary mucormycosis in a patient with kidney transplant and uncontrolled haemoptysis]. Navarro Vergara DI; Barragán Pola G; Bonifaz A; Núñez Pérez-Redondo C; Choreño García O; Cicero Sabido R Rev Iberoam Micol; 2017; 34(4):233-236. PubMed ID: 28757006 [TBL] [Abstract][Full Text] [Related]
33. Amphotericin B Resistant Apophysomyces elegans Causing Rhino-oculo-Cerebral Mucormycosis in an Immunocompetent Host. Biswas D; Kotwal A; Kakati B; Ahmad S J Clin Diagn Res; 2015 Aug; 9(8):DD01-2. PubMed ID: 26435947 [TBL] [Abstract][Full Text] [Related]
34. [Evaluation of zygomycosis cases by pooled analysis method reported from Turkey]. Zeka AN; Taşbakan M; Pullukçu H; Sipahi OR; Yamazhan T; Arda B Mikrobiyol Bul; 2013 Oct; 47(4):708-16. PubMed ID: 24237440 [TBL] [Abstract][Full Text] [Related]
35. Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Prabhu RM; Patel R Clin Microbiol Infect; 2004 Mar; 10 Suppl 1():31-47. PubMed ID: 14748801 [TBL] [Abstract][Full Text] [Related]
36. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848 [TBL] [Abstract][Full Text] [Related]
37. Multicenter evaluation of MIC distributions for epidemiologic cutoff value definition to detect amphotericin B, posaconazole, and itraconazole resistance among the most clinically relevant species of Mucorales. Espinel-Ingroff A; Chakrabarti A; Chowdhary A; Cordoba S; Dannaoui E; Dufresne P; Fothergill A; Ghannoum M; Gonzalez GM; Guarro J; Kidd S; Lass-Flörl C; Meis JF; Pelaez T; Tortorano AM; Turnidge J Antimicrob Agents Chemother; 2015 Mar; 59(3):1745-50. PubMed ID: 25583714 [TBL] [Abstract][Full Text] [Related]
38. Mucormycosis due to Apophysomyces species complex- 25 years' experience at a tertiary care hospital in southern India. Pamidimukkala U; Sudhaharan S; Kancharla A; Vemu L; Challa S; Karanam SD; Chavali P; Prakash H; Ghosh AK; Gupta S; Rudramurthy SM; Chakrabarti A Med Mycol; 2020 Jun; 58(4):425-433. PubMed ID: 31342074 [TBL] [Abstract][Full Text] [Related]
39. Disseminated Mucormycosis With Cerebral Involvement Owing to Rhizopus Microsporus in a Kidney Recipient Treated With Combined Liposomal Amphotericin B and Posaconazole Therapy. Ville S; Talarmin JP; Gaultier-Lintia A; Bouquié R; Sagan C; Le Pape P; Giral M; Morio F Exp Clin Transplant; 2016 Feb; 14(1):96-9. PubMed ID: 25275881 [TBL] [Abstract][Full Text] [Related]
40. Invasive mucormycosis in children: an epidemiologic study in European and non-European countries based on two registries. Pana ZD; Seidel D; Skiada A; Groll AH; Petrikkos G; Cornely OA; Roilides E; BMC Infect Dis; 2016 Nov; 16(1):667. PubMed ID: 27832748 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]